To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...

PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the association of ...

Adjuvant radiotherapy could substantially reduce risk for locoregional recurrence for patients with advanced muscle-invasive ...

Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...

Post-surgery radiation slashes the risk of locoregional recurrence in patients with advanced muscle-invasive bladder cancer — but what is its role alongside immunotherapy?

MIBC requires a multimodal treatment approach, with radical cystectomy as the gold standard and bladder-sparing options for select patients. Adjuvant immunotherapies, such as nivolumab and ...

Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC.

—A retrospective real-world study of patients with muscle-invasive bladder cancer showed that robot-assisted and laparoscopic radical cystectomy reduce post-surgical complication rates, compared to ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

This was a single-center, retrospective analysis of 42 patients with MIBC who underwent TMT at the Moffitt Cancer Center ...

Researchers have identified in a new study that perioperative dynamic alterations in systemic inflammatory markers are highly ...

A groundbreaking Indian study, the BART trial, highlights that radiation therapy post-surgery safely reduces pelvic relapse ...